Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Prophylaxis Strategy for Flexible Ureteroscopic Lithotripsy
NCT07246967Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Feb 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in urinary tract infection (UTI) and Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Incidence of Systemic Inflammatory Response Syndrome (SIRS) at 72 hours. Started Feb 2026; status: recruiting.
02
Conditions
urinary tract infection (UTI)Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT07246967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246967.